Overview
Lushan Xiao practices practicing medicine in Guangzhou, China.
Their clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Cerebral Hypoxia, Liver Cancer, and Hepatitis.
They are actively involved in clinical research, co-authoring 30 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Lushan Xiao
Is Lushan Xiao a top-rated expert for Non-Alcoholic Fatty Liver Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Lushan Xiao is classified as an Experienced expert for Non-Alcoholic Fatty Liver Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Lushan Xiao participate in research or clinical trials?
Yes. Lushan Xiao has published 30 articles and abstracts on conditions like Non-Alcoholic Fatty Liver Disease. You can view a list of Lushan Xiao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cerebral HypoxiaXiao isExperienced. Learn about Cerebral Hypoxia.
- GallstonesXiao isExperienced. Learn about Gallstones.
- HepatitisXiao isExperienced. Learn about Hepatitis.
- Liver CancerXiao isExperienced. Learn about Liver Cancer.
- Non-Alcoholic Fatty Liver Disease